E-Z-EM (Lake Success, New York) reported that its board has approved the decision to switch the listing of the company's common stock from the American Stock Exchange to the Nasdaq National Market. Effective April 12, the company's stock will begin trading under the symbol Nasdaq:EZEM. The stock will continue to trade on the American Stock Exchange until the effective date.

Paul Echenberg, chairman of the E-Z-EM board, said, "This decision was reached after careful consideration of the capital market alternatives. We believe that trading on the Nasdaq National Market will allow us to increase the liquidity of our stock and increase the visibility of the company, while at the same time providing investors with the best prices, the fastest execution, and the lowest cost per trade."

E-Z-EM is a manufacturer of contrast agents for gastrointestinal radiology.